Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

ML-Based Multi-Sensor Fall Risk Screening in DMD

Quantitative Analysis of Upper Extremity Functional Movement of the Upper Extremity in Patients With Duchenne Muscular Dystrophy

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This prospective observational study aims to analyze changes in upper extremity functional movement over time in children with Duchenne Muscular Dystrophy (DMD). Thirty patients will be evaluated at three time points (baseline, 6 months, 12 months) using clinical assessments (PUL 2.0, Brooke Scale, grip strength), computer vision-based video analysis, and machine learning algorithms. The goal is to improve future upper limb evaluation methods for non-ambulatory DMD patients. The study includes safety monitoring and adheres to ethical standards, ensuring patient data confidentiality and providing compensation if adverse effects occur.

Who May Be Eligible (Plain English)

Who May Qualify: 1. Individuals with a confirmed genetic diagnosis of Duchenne Muscular Dystrophy (DMD) 2. Age over 10 and under 30 years 3. Brooke Scale score between 2 and 5 4. Manual muscle test grade below 3 for shoulder abduction muscles Who Should NOT Join This Trial: 1. Individuals who are unable or unwilling to provide willing to sign a consent form 2. Brooke Scale score of 1 or 6 3. Individuals with cognitive impairments that significantly limit their ability to participate in assessments Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: 1. Individuals with a confirmed genetic diagnosis of Duchenne Muscular Dystrophy (DMD) 2. Age over 10 and under 30 years 3. Brooke Scale score between 2 and 5 4. Manual muscle test grade below 3 for shoulder abduction muscles Exclusion Criteria: 1. Individuals who are unable or unwilling to provide informed consent 2. Brooke Scale score of 1 or 6 3. Individuals with cognitive impairments that significantly limit their ability to participate in assessments

Treatments Being Tested

OTHER

Performance of the Upper Limb, Brooke Scale, grip strength test

Thirty patients will be evaluated at three time points (baseline, 6 months, 12 months) using clinical assessments (PUL 2.0, Brooke Scale, grip strength), computer vision-based video analysis, and machine learning algorithms.

Locations (1)

Seoul National University Hospital
Seoul, Jongno, South Korea